BRCA1 is required for hMLH1 stabilization following doxorubicin-induced DNA damage

  • Francesco Romeo, Lucia Falbo, Maddalena Di Sanzo, Roberta Misaggi, Maria C. Faniello, Giuseppe Viglietto, Giovanni Cuda, Francesco Costanzo, Barbara Quaresima
  • The International Journal of Biochemistry & Cell Biology, December 2011, Elsevier
  • DOI: 10.1016/j.biocel.2011.08.011

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.biocel.2011.08.011

The following have contributed to this page: PhD Lucia L Falbo